Collectively, these results indicate that DCAF8L1 is aberrantly expressed in breast cancer cell lines and tissues, suggesting that alteration of DCAF8L1 might be associated with breast cancer progression and development. This evidence concerns the gene DCAF8L1 and breast carcinoma.